V. Opoka-Winiarska

发表

Effect of rapid cessation of enzyme replacement therapy: a report of 5 cases and a review of the literature.

G. Węgrzyn, A. Tylki-Szymańska, A. Jurecka, 2012, Molecular genetics and metabolism.

The importance of FDG PET/CT in the diagnostic process of the middle aortic syndrome in a 15-year-old boy patient with suspected systemic vasculitis and final diagnosis of Williams–Beuren syndrome

M. Lejman, M. Woźniak, V. Opoka-Winiarska, 2020, Rheumatology International.

Etanercept treatment in juvenile idiopathic arthritis: The Polish registry

P. Wiland, Z. Żuber, L. Rutkowska-Sak, 2011, Medical science monitor : international medical journal of experimental and clinical research.

The clinical profile of Kawasaki disease of children from three Polish centers: a retrospective study

D. Gorczyca, M. Lubieniecka, V. Opoka-Winiarska, 2013, Rheumatology International.

Mucopolysaccharidosis type VI: A predominantly cardiac phenotype associated with homozygosity for p.R152W mutation in the ARSB gene

A. Tylki-Szymańska, N. Gusina, E. Zakharova, 2013, American journal of medical genetics. Part A.

The role of cytokines in juvenile idiopathic arthritis

J. Roliński, J. Tabarkiewicz, V. Opoka-Winiarska, 2008 .

Clinical remission in juvenile idiopathic arthritis after termination of etanercept

V. Opoka-Winiarska, J. Postępski, E. Olesińska, 2012, Rheumatology International.

Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study

J. Roliński, E. Grywalska, I. Korona-Głowniak, 2022, Journal of clinical medicine.

Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report

J. Roliński, F. Burdan, E. Starosławska, 2018, BMC Infectious Diseases.

AB1112 DIAGNOSTIC DELAY AND DAMAGE OF POLISH ADULT PATIENTS AFFECTED BY HEREDITARY AUTOINFLAMMATORY SYNDROMES

S. Niemczyk, K. Jahnz-Różyk, E. Więsik-Szewczyk, 2019, Abstracts Accepted for Publication.

PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection—“Rheumatic Fever” of the 21st Century?

J. Roliński, E. Grywalska, V. Opoka-Winiarska, 2021, International journal of molecular sciences.

Is It Inflammatory Bowel Disease Flare or Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19?

E. Pac-Kożuchowska, V. Opoka-Winiarska, Paulina Krawiec, 2022, Journal of clinical medicine.

Neurologic Presentation, Diagnostics, and Therapeutic Insights in a Severe Case of Adenylosuccinate Lyase Deficiency

A. Tylki-Szymańska, D. Rokicki, A. Jurecka, 2012, Journal of child neurology.

Problems of patients with cystic fibrosis during transition to adulthood.

J. Kozielski, H. Mazurek, V. Opoka-Winiarska, 2015, Pneumonologia i alergologia polska.

Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study

J. Roliński, E. Grywalska, I. Korona-Głowniak, 2021, Journal of clinical medicine.

Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?

J. Roliński, E. Grywalska, V. Opoka-Winiarska, 2020, BMC Medicine.

Mucopolysaccharidosis type VI: a cardiologist's guide to diagnosis and treatment.

A. Tylki-Szymańska, A. Golda, A. Jurecka, 2013, International journal of cardiology.

Spinal Cord Compression in Maroteaux-Lamy Syndrome: Case Report and Review of the Literature with Effects of Enzyme Replacement Therapy

A. Tylki-Szymańska, E. Jurkiewicz, J. Marucha, 2012, Pediatric Neurosurgery.

Rheumatological aspects of mucopolysaccharidoses

A. Tylki-Szymańska, A. Emeryk, A. Jurecka, 2012 .

Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.

A. Tylki-Szymańska, A. Emeryk, A. Jurecka, 2013, Osteoarthritis and cartilage.

Differential diagnosis in children with musculoskeletal pain in Emergency Department

Małgorzata Drozd, V. Opoka-Winiarska, Bartłomiej Zaremba, 2022, Journal of Education, Health and Sport.

Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis—A observational study from two pediatric rheumatology centres in Poland

V. Opoka-Winiarska, E. Smolewska, J. Lipinska, 2023, Frontiers in Pediatrics.

COVID-19 vaccination in patients with rheumatic diseases — status February 2022

V. Opoka-Winiarska, E. Smolewska, 2022, Rheumatology Forum.

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

E. Alexeeva, E. Silverman, V. Chasnyk, 2014, Annals of the rheumatic diseases.

The Impact of Epstein-Barr Virus Infection on Juvenile Idiopathic Arthritis Activity and Patient’s Response to Treatment

J. Roliński, E. Grywalska, V. Opoka-Winiarska, 2020, Journal of clinical medicine.

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype.

A. Tylki-Szymańska, E. Piotrowska, A. Golda, 2011, Molecular genetics and metabolism.

Diseases of the respiratory system in patients with juvenile idiopatic arthritis

E. Czekajska-Chehab, V. Opoka-Winiarska, J. Postępski, 2005 .

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.

E. Alexeeva, E. Silverman, V. Chasnyk, 2015, Annals of the rheumatic diseases.

Diagnostics and imaging procedures

V. Opoka-Winiarska, D. Sołdacki, Aleksandra Matyja-Bednarczyk, 2023 .

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

E. Alexeeva, P. Quartier, D. Siri, 2014, Annals of the rheumatic diseases.